START OF PAGE 1
WES MOORE, Governor Ch. 234

Chapter 234

(House Bill 1074)

AN ACT concerning

Health Insurance – Mental Health and Substance Use Disorder Benefits –
Sunset Repeal and Modification of Reporting Requirements

FOR the purpose of altering certain reporting requirements on health insurance carriers
relating to compliance with the federal Mental Health Parity and Addiction Equity
Act; altering requirements for certain analyses of nonquantitative treatment
limitations required of health insurance carriers; ~~authorizing~~ ~~the~~ ~~Maryland~~
~~Insurance~~ ~~Commissioner~~ ~~to~~ ~~exercise~~ ~~discretion~~ ~~to~~ ~~review~~ ~~subsets~~ ~~of~~ ~~nonquantitative~~
~~treatment~~ ~~limitations~~ ~~under~~ ~~certain~~ ~~circumstances;~~ establishing certain remedies
the Commissioner may use to enforce compliance with the Mental Health Parity and
Addiction Equity Act and related reporting requirements; establishing that a health
insurance carrier has the burden of persuasion in demonstrating that its health plan
complies with the federal Mental Health Parity and Addiction Equity Act; repealing
the requirement that the Commissioner use a certain form for the reporting
requirements; repealing the termination date for the reporting requirements; and
generally relating to health insurance carriers and mental health and substance use
disorder benefits.

BY repealing and reenacting, with amendments,
Article – Insurance
Section 15–144
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)

BY repealing and reenacting, without amendments,
Article – Insurance
Section 15–1309(a)(1) and (3)
Annotated Code of Maryland
(2017 Replacement Volume and 2023 Supplement)

BY repealing
Chapter 211 of the Acts of the General Assembly of 2020
Section 2

BY repealing and reenacting, with amendments,
Chapter 211 of the Acts of the General Assembly of 2020
Section 4

BY repealing
Chapter 212 of the Acts of the General Assembly of 2020
Section 2
– 1 –
END OF PAGE 1

START OF PAGE 2
Ch. 234 2024 LAWS OF MARYLAND

BY repealing and reenacting, with amendments,
Chapter 212 of the Acts of the General Assembly of 2020
Section 4

SECTION 1. BE IT ENACTED BY THE GENERAL ASSEMBLY OF MARYLAND,
That the Laws of Maryland read as follows:

Article – Insurance

15–144.

(a) (1) In this section the following words have the meanings indicated.

(2) “Carrier” means:

(i) an insurer that holds a certificate of authority in the State and
provides health insurance in the State;

(ii) a health maintenance organization that is licensed to operate in
the State;

(iii) a nonprofit health service plan that is licensed to operate in the
State; or

(iv) any other person or organization that provides health benefit
plans subject to State insurance regulation.

(3) “Health benefit plan” means:

(i) for a large group or blanket plan, a health benefit plan as defined
in § 15–1401 of this title;

(ii) for a small group plan, a health benefit plan as defined in §
15–1201 of this title;

(iii) for an individual plan:

1. a health benefit plan as defined in § 15–1301(l) of this title;
or

2. an individual health benefit plan as defined in §
15–1301(o) of this title;

(iv) short–term limited duration insurance as defined in § 15–1301(s)
of this title; or

– 2 –
END OF PAGE 2

START OF PAGE 3
WES MOORE, Governor Ch. 234

(v) a student health plan as defined in § 15–1318(a) of this title.

(4) “Medical/surgical benefits” has the meaning stated in 45 C.F.R. §
146.136(a) and 29 C.F.R. § 2590.712(a).

(5) “Mental health benefits” has the meaning stated in 45 C.F.R. §
146.136(a) and 29 C.F.R. § 2590.712(a).

(6) “Nonquantitative treatment limitation” means treatment limitations
as defined in 45 C.F.R. § 146.136(a) and 29 C.F.R. § 2590.712(a).

(7) (I) “Parity Act” means the Paul Wellstone and Pete Domenici
Mental Health Parity and Addiction Equity Act of 2008 [and 45 C.F.R. § 146.136 and 29
C.F.R. § 2590.712], AS AMENDED.

(II) “PARITY ACT” INCLUDES 45 C.F.R. § 146.136, 29 C.F.R. §
2590.712, AND ANY OTHER RELATED FEDERAL REGULATIONS FOUND IN THE CODE
OF FEDERAL REGULATIONS TO IMPLEMENT OR ENFORCE THE PAUL WELLSTONE
AND PETE DOMENICI MENTAL HEALTH PARITY AND ADDICTION EQUITY ACT OF
2008.

(8) “Parity Act classification” means:

(i) inpatient in–network benefits;

(ii) inpatient out–of–network benefits;

(iii) outpatient in–network benefits;

(iv) outpatient out–of–network benefits;

(v) prescription drug benefits; and

(vi) emergency care benefits.

(9) “PRODUCT” HAS THE MEANING STATED IN § 15–1309(A)(3) OF
THIS TITLE.

(9) (10) “Substance use disorder benefits” has the meaning stated in 45
C.F.R. § 146.136(a) and 29 C.F.R. § 2590.712(a).

(b) This section applies to a carrier that delivers or issues for delivery a health
benefit plan in the State.

– 3 –
END OF PAGE 3

START OF PAGE 4
Ch. 234 2024 LAWS OF MARYLAND

(C) (1) EACH CARRIER SUBJECT TO THIS SECTION SHALL:

(I) FOR EACH PARITY ACT CLASSIFICATION, IDENTIFY ALL
NONQUANTITATIVE TREATMENT LIMITATIONS THAT ARE APPLIED TO MENTAL
HEALTH BENEFITS, SUBSTANCE USE DISORDER BENEFITS, AND MEDICAL/SURGICAL
BENEFITS;

(II) IN ACCORDANCE WITH THE PARITY ACT, PERFORM AND
DOCUMENT COMPARATIVE ANALYSES OF THE DESIGN AND APPLICATION OF ALL
NONQUANTITATIVE TREATMENT LIMITATIONS IMPOSED ON MENTAL HEALTH
BENEFITS AND SUBSTANCE USE DISORDER BENEFITS;

(III) PROVIDE THE COMPARATIVE ANALYSIS FOR EACH
NONQUANTITATIVE TREATMENT LIMITATION REQUESTED BY THE COMMISSIONER
WITHIN:

1. 15 WORKING DAYS AFTER A WRITTEN REQUEST; OR

2. IF ADOPTED BY THE FEDERAL GOVERNMENT, LESS
THAN 15 WORKING DAYS TO ALIGN WITH THE FEDERAL RULE OR REGULATION;

(IV) WITHIN 30 DAYS AFTER A WRITTEN REQUEST, PROVIDE THE
COMPARATIVE ANALYSIS FOR EACH NONQUANTITATIVE TREATMENT LIMITATION
AND RELATED IN OPERATION DATA ANALYSIS, IF AVAILABLE AND REQUESTED BY A
MEMBER IN ACCORDANCE WITH THE PARITY ACT DISCLOSURE REQUIREMENTS OR,
FOR MEMBERS WITH INDIVIDUAL PLANS, IN ACCORDANCE WITH SUBSECTION (E)(7)
OF THIS SECTION; AND

(V) SUBMIT THE REPORTS REQUIRED UNDER PARAGRAPH (2)
OF THIS SUBSECTION.

(c) (1) (2) On or before [March 1, 2022, and March 1, 2024] MARCH 1
EACH YEAR, BEGINNING IN 2025 JULY 1, 2024, AND EVERY 2 YEARS THEREAFTER,
each carrier subject to this section shall:

~~(i)~~ ~~identify~~ ~~the~~ ~~five~~ ~~health~~ ~~benefit~~ ~~plans~~ ~~with~~ ~~the~~ ~~highest~~ ~~enrollment~~
~~for~~ ~~each~~ ~~product~~ ~~offered~~ ~~by~~ ~~the~~ ~~carrier~~ ~~in~~ ~~the~~ ~~individual,~~ ~~small,~~ ~~and~~ ~~large~~ ~~group~~ ~~markets;~~
~~and~~

(ii) submit a report to the Commissioner ON EACH PRODUCT
OFFERED BY THE CARRIER IN THE INDIVIDUAL, SMALL, AND LARGE GROUP
MARKETS to demonstrate the carrier’s compliance with the Parity Act.

– 4 –
END OF PAGE 4

START OF PAGE 5
WES MOORE, Governor Ch. 234

(2) (3) The report submitted under paragraph (1) (2) of this subsection
shall include [the following information]:

(I) ALL NONQUANTITATIVE TREATMENT LIMITATION
COMPARATIVE ANALYSIS INFORMATION REQUIRED UNDER THE PARITY ACT,
SUBSECTION (D) OF THIS SECTION, AND ANY STATE REGULATIONS for the health
benefit plans identified PRODUCTS IDENTIFIED under [item] PARAGRAPH (1)(i) (2) of
this subsection;, INCLUDING:

~~(i)~~ ~~a~~ ~~description~~ ~~of~~ ~~the~~ ~~process~~ ~~used~~ ~~to~~ ~~develop~~ ~~or~~ ~~select~~ ~~the~~ ~~medical~~
~~necessity~~ ~~criteria~~ ~~for~~ ~~mental~~ ~~health~~ ~~benefits~~ ~~and~~ ~~substance~~ ~~use~~ ~~disorder~~ ~~benefits~~ ~~and~~ ~~the~~
~~process~~ ~~used~~ ~~to~~ ~~develop~~ ~~or~~ ~~select~~ ~~the~~ ~~medical~~ ~~necessity~~ ~~criteria~~ ~~for~~ ~~medical~~ ~~and~~ ~~surgical~~
~~benefits;~~

~~(ii)~~ ~~for~~ ~~each~~ ~~Parity~~ ~~Act~~ ~~classification,~~ ~~identification~~ ~~of~~
~~nonquantitative~~ ~~treatment~~ ~~limitations~~ ~~that~~ ~~are~~ ~~applied~~ ~~to~~ ~~mental~~ ~~health~~ ~~benefits~~ ~~and~~
~~substance~~ ~~use~~ ~~disorder~~ ~~benefits~~ ~~and~~ ~~medical~~ ~~and~~ ~~surgical~~ ~~benefits;~~

~~(iii)~~ ~~identification~~ ~~of~~ ~~the~~ ~~description~~ ~~of~~ ~~the~~ ~~nonquantitative~~ ~~treatment~~
~~limitations~~ ~~identified~~ ~~under~~ ~~item~~ ~~(ii)~~ ~~of~~ ~~this~~ ~~paragraph~~ ~~in~~ ~~documents~~ ~~and~~ ~~instruments~~ ~~under~~
~~which~~ ~~the~~ ~~plan~~ ~~is~~ ~~established~~ ~~or~~ ~~operated;~~ ~~and~~

(iv) (II) the results of the A comparative analysis as described
under subsections (d) and (e) of this section. CONDUCTED BY THE CARRIER ON NOT
FEWER THAN FIVE NONQUANTITATIVE TREATMENT LIMITATIONS SELECTED BY THE
COMMISSIONER IN ACCORDANCE WITH PARAGRAPH (5) OF THIS SUBSECTION; AND

(III) SUBJECT TO PARAGRAPH (4) OF THIS SUBSECTION, A
STATEMENT, SIGNED BY A CORPORATE OFFICER, ATTESTING THAT, FOR EACH
PRODUCT IDENTIFIED UNDER PARAGRAPH (2) OF THIS SUBSECTION, THE SELECTED
NONQUANTITATIVE TREATMENT LIMITATIONS AND THE PROCESSES, STRATEGIES,
EVIDENTIARY STANDARDS, OR OTHER FACTORS USED IN DESIGNING AND APPLYING
THE SELECTED NONQUANTITATIVE TREATMENT LIMITATIONS TO MENTAL HEALTH
BENEFITS, SUBSTANCE USE DISORDER BENEFITS, AND MEDICAL/SURGICAL
BENEFITS ARE THE SAME FOR ALL PLANS WITHIN THE PRODUCT, AS WRITTEN AND
IN OPERATION.

(4) IF, FOR ANY PLAN WITHIN A PRODUCT IDENTIFIED UNDER
PARAGRAPH (2) OF THIS SUBSECTION, THE PROCESSES, STRATEGIES, EVIDENTIARY
STANDARDS, OR OTHER FACTORS USED IN DESIGNING AND APPLYING THE
SELECTED NONQUANTITATIVE TREATMENT LIMITATIONS TO MENTAL HEALTH
BENEFITS, SUBSTANCE USE DISORDER BENEFITS, OR MEDICAL/SURGICAL BENEFITS
ARE DIFFERENT, AS WRITTEN OR IN OPERATION, FROM THE OTHER PLANS WITHIN
THE PRODUCT:

– 5 –
END OF PAGE 5

START OF PAGE 6
Ch. 234 2024 LAWS OF MARYLAND

(I) THE STATEMENT REQUIRED UNDER PARAGRAPH (3)(III) OF
THIS SUBSECTION SHALL NOTE THE EXCEPTION AND IDENTIFY THE PLAN; AND

(II) THE CARRIER SHALL SUBMIT A SEPARATE COMPARATIVE
ANALYSIS FOR THE SELECTED NONQUANTITATIVE TREATMENT LIMITATIONS FOR
THE PLAN.

(5) (I) IN SELECTING THE NONQUANTITATIVE TREATMENT
LIMITATIONS REQUIRED TO BE INCLUDED FOR EACH REPORTING PERIOD, THE
COMMISSIONER:

1. SHALL PRIORITIZE THE NONQUANTITATIVE
TREATMENT LIMITATIONS IDENTIFIED BY THE COMMISSIONER AS HAVING THE
GREATEST IMPACT ON MEMBER ACCESS TO CARE;

2. SHALL REVIEW THE SAME SUBSET OF
NONQUANTITATIVE TREATMENT LIMITATIONS FOR EACH CARRIER REPORT; AND

3. MAY TAKE INTO CONSIDERATION OTHER FACTORS
DETERMINED RELEVANT BY THE COMMISSIONER, INCLUDING COMPLAINT TRENDS,
FEDERAL PARITY ACT GUIDANCE, AND WHETHER THE NONQUANTITATIVE
TREATMENT LIMITATION WAS SELECTED FOR A PREVIOUS REPORTING YEAR.

(II) OF THE FIVE SELECTED NONQUANTITATIVE TREATMENT
LIMITATIONS:

1. NOT MORE THAN TWO MAY BE FOR UTILIZATION
REVIEW; AND

2. AT LEAST ONE MUST BE FOR NETWORK COMPOSITION,
INCLUDING REIMBURSEMENT RATE SETTING.

(6) A FINDING OF NONCOMPLIANCE FOR A PRODUCT SHALL APPLY TO
ALL PLANS WITHIN THE PRODUCT.

(d) (1) A carrier subject to this section shall conduct a comparative analysis
for the nonquantitative treatment limitations identified SELECTED under subsection
(c)(2)(ii) (C)(5) of this section as nonquantitative treatment limitations are:

(i) written; and

(ii) in operation.

– 6 –
END OF PAGE 6

START OF PAGE 7
WES MOORE, Governor Ch. 234

(2) The comparative analysis of the nonquantitative treatment limitations
identified SELECTED under subsection (c)(2)(ii) (C)(5) of this section shall:

(I) demonstrate that the processes, strategies, evidentiary
standards, or other factors used in DESIGNING AND applying the medical necessity criteria
and each SELECTED nonquantitative treatment limitation to mental health benefits and
substance use disorder benefits in each Parity Act classification are comparable to, and are
applied no more stringently than, the processes, strategies, evidentiary standards, or other
factors used in DESIGNING AND applying the medical necessity criteria and each
SELECTED nonquantitative treatment limitation to medical and surgical
MEDICAL/SURGICAL benefits within the same Parity Act classification; AND

(II) INCLUDE ALL INFORMATION REQUIRED UNDER THE PARITY
ACT.

(3) REGARDLESS OF WHETHER IT WAS USED BEFORE THE PARITY
ACT WAS ENACTED AND AS REQUESTED BY THE COMMISSION, A CARRIER SHALL
PERFORM AND PROVIDE A COMPARATIVE ANALYSIS FOR EACH PROCESS, STRATEGY,
EVIDENTIARY STANDARD, OR OTHER FACTOR USED IN DESIGNING AND APPLYING A
SELECTED NONQUANTITATIVE TREATMENT LIMITATION USED DURING A
REPORTING PERIOD.

(e) In providing the analysis required under subsection (d) of this section, a
carrier shall:

(1) identify the factors used to determine that a nonquantitative treatment
limitation will apply to a benefit, including:

(i) the sources for the factors, INCLUDING SOURCES IN EFFECT
BEFORE THE ENACTMENT OF THE PARITY ACT;

(ii) the factors that were considered but rejected; [and]

(III) THE FACTORS THAT WERE IN EFFECT BEFORE THE
ENACTMENT OF THE PARITY ACT AND ARE USED IN THE DESIGN OR APPLICATION
OF THE NONQUANTITATIVE TREATMENT LIMITATION; AND

[(iii)] (IV) if a factor was given more weight than another, the reason
for the difference in weighting;

(2) identify and define the specific evidentiary standards used to define the
factors and any other evidence relied on in designing each nonquantitative treatment
limitation, INCLUDING EVIDENTIARY STANDARDS IN EFFECT BEFORE THE
ENACTMENT OF THE PARITY ACT;

– 7 –
END OF PAGE 7

START OF PAGE 8
Ch. 234 2024 LAWS OF MARYLAND

(3) IDENTIFY AND DEFINE THE PROCESSES AND STRATEGIES THAT
ARE USED TO DESIGN OR APPLY THE NONQUANTITATIVE TREATMENT LIMITATION,
~~INCLUDING~~ ~~THE~~ ~~PROCESSES~~ ~~AND~~ ~~STRATEGIES~~ ~~IN~~ ~~EFFECT~~ ~~BEFORE~~ ~~THE~~ ~~ENACTMENT~~
OF THE PARITY ACT;

[(3)] (4) include the results of the audits, reviews, and analyses
performed on the nonquantitative treatment limitations identified under subsection
(c)(2)(ii) (C)(5) of this section to conduct the analysis required under subsection (d)(2) of
this section for the plans AND PRODUCTS as written;

[(4)] (5) include the results of the audits, reviews, and analyses
performed on the nonquantitative treatment limitations identified under subsection
(c)(2)(ii) (C)(5) of this section to conduct the analysis required under subsection (d)(2) of
this section for the plans AND PRODUCTS as in operation;

[(5)] (6) identify the measures used to ensure comparable design and
application of nonquantitative treatment limitations that are implemented by the carrier
and any entity delegated by the carrier to manage mental health benefits, substance use
disorder benefits, or medical/surgical benefits on behalf of the carrier;

[(6)] (7) disclose the specific findings and conclusions reached by the
carrier that indicate that the health benefit plan is in compliance with this section and the
Parity Act [and its implementing regulations, including 45 C.F.R. 146.136 and 29 C.F.R.
2590.712 and any other related federal regulations found in the Code of Federal
Regulations]; and

[(7)] (8) identify the process used to comply with the Parity Act disclosure
requirements for mental health benefits, substance use disorder benefits, and
medical/surgical benefits, including:

(i) the criteria for a medical necessity determination;

(ii) reasons for a denial of benefits; and

(iii) in connection with a member’s request for INDIVIDUAL OR group
plan information and for purposes of filing an internal coverage or grievance matter and
appeals, plan documents that contain information about processes, strategies, evidentiary
standards, and any other factors used to apply a nonquantitative treatment limitation.

(f) On or before [March 1, 2022, and March 1, 2024] MARCH 1 EACH YEAR,
BEGINNING IN 2025, each carrier subject to this section shall submit a report for the
~~health~~ ~~benefit~~ ~~plans~~ ~~identified~~ ~~under~~ ~~subsection~~ ~~(c)(1)(i)~~ ~~of~~ ~~this~~ ~~section~~ ~~to~~ ~~the~~ ~~Commissioner~~
~~on~~ ~~the~~ ~~following~~ ~~data~~ ~~for~~ ~~the~~ ~~immediately~~ ~~preceding~~ ~~calendar~~ ~~year~~ ~~for~~ ~~mental~~ ~~health~~

– 8 –
END OF PAGE 8

START OF PAGE 9
WES MOORE, Governor Ch. 234

~~benefits,~~ ~~substance~~ ~~use~~ ~~disorder~~ ~~benefits,~~ ~~and~~ ~~medical/surgical~~ ~~benefits~~ ~~by~~ ~~Parity~~ ~~Act~~
~~classification:~~

~~(1)~~ ~~the~~ ~~frequency,~~ ~~reported~~ ~~by~~ ~~number~~ ~~and~~ ~~rate,~~ ~~with~~ ~~which~~ ~~the~~ ~~health~~
~~benefit~~ ~~plan~~ ~~received,~~ ~~approved,~~ ~~and~~ ~~denied~~ ~~prior~~ ~~authorization~~ ~~requests~~ ~~for~~ ~~mental~~ ~~health~~
~~benefits,~~ ~~substance~~ ~~use~~ ~~disorder~~ ~~benefits,~~ ~~and~~ ~~medical~~ ~~and~~ ~~surgical~~ ~~benefits~~ ~~in~~ ~~each~~ ~~Parity~~
Act classification during the immediately preceding calendar year; [and]

~~(2)~~ ~~the~~ ~~number~~ ~~of~~ ~~claims~~ ~~submitted~~ ~~for~~ ~~mental~~ ~~health~~ ~~benefits,~~ ~~substance~~
~~use~~ ~~disorder~~ ~~benefits,~~ ~~and~~ ~~medical~~ ~~and~~ ~~surgical~~ ~~benefits~~ ~~in~~ ~~each~~ ~~Parity~~ ~~Act~~ ~~classification~~
~~during~~ ~~the~~ ~~immediately~~ ~~preceding~~ ~~calendar~~ ~~year~~ ~~and~~ ~~the~~ ~~number~~ ~~and~~ ~~rates~~ ~~of,~~ ~~and~~ ~~reasons~~
for, denial of claims; AND

(3) DATA IDENTIFIED BY THE COMMISSIONER OR FEDERAL
~~REGULATIONS~~ ~~TO~~ ~~EVALUATE~~ ~~NONQUANTITATIVE~~ ~~TREATMENT~~ ~~LIMITATION~~
COMPLIANCE WITH THE IN–OPERATION STANDARD OF THE PARITY ACT.

(F) THE COMMISSIONER SHALL:

(1) DEVELOP ADDITIONAL STANDARDIZED DATA TEMPLATES:

(I) TO EVALUATE THE COMPARATIVE ANALYSIS OF
NONQUANTITATIVE TREATMENT LIMITATIONS IN OPERATION; AND

(II) THAT MEET OR EXCEED ANY MINIMUM REQUIREMENTS FOR
DATA REPORTING SPECIFIED IN FEDERAL REGULATIONS;

(2) REQUIRE EACH CARRIER SUBJECT TO THIS SECTION TO SUBMIT:

(I) FOR EACH PRODUCT IDENTIFIED UNDER SUBSECTION
(C)(2) OF THIS SECTION, THE DATA TEMPLATES DESCRIBED IN ITEM (1) OF THIS
SUBSECTION FOR THE NONQUANTITATIVE TREATMENT LIMITATIONS SELECTED BY
THE COMMISSIONER FOR THE REPORTING YEAR IN ACCORDANCE WITH SUBSECTION
(C)(5) OF THIS SECTION; AND

(II) A SEPARATE DATA TEMPLATE FOR ANY PLANS DESCRIBED
IN SUBSECTION (C)(4) OF THIS SECTION; AND

(3) POST THE DATA TEMPLATES ON THE ADMINISTRATION’S WEBSITE
FOR A COMMENT PERIOD OF NOT LESS THAN 30 DAYS BEFORE ADOPTION.

(g) The reports required under ~~subsections~~ ~~(c)~~ ~~and~~ ~~(f)~~ ~~of~~ this section shall:

(1) be submitted on a standard form developed by the Commissioner THAT
~~CONFORMS~~ ~~TO~~ MEETS OR EXCEEDS ANY MINIMUM REQUIREMENTS SPECIFIED IN
– 9 –
END OF PAGE 9

START OF PAGE 10
Ch. 234 2024 LAWS OF MARYLAND

THE FEDERAL REGULATIONS AND SUB–REGULATORY GUIDANCE ON
NONQUANTITATIVE TREATMENT LIMITATIONS ~~COMPARATIVE~~ ~~ANALYSIS~~
REPORTING;

(2) be submitted by the carrier that issues or delivers the ~~health~~ ~~benefit~~
~~plan~~ PRODUCT;

(3) be prepared in coordination with any entity the carrier contracts with
to provide mental health benefits and substance use disorder benefits;

(4) contain a statement, signed by a corporate officer, attesting to the
accuracy of the information contained in the report;

(5) be available to plan members and the public on the carrier’s website in
a summary form that removes confidential or proprietary information and is developed by
the Commissioner in accordance with subsection [(m)(2)] (N)(2) of this section; and

(6) exclude any identifying information of any plan member.

(h) (1) A carrier submitting a report under ~~subsections~~ ~~(c)~~ ~~and~~ ~~(f)~~ ~~of~~ this section
may submit a written request to the Commissioner that disclosure of specific information
included in the report be denied under the Public Information Act and, if submitting a
request, shall:

(i) identify the particular information the disclosure of which the
carrier requests be denied; and

(ii) cite the statutory authority under the Public Information Act
that authorizes denial of access to the information.

(2) The Commissioner may review a request submitted under paragraph
(1) of this subsection on receipt of a request for access to the information under the Public
Information Act.

(3) The Commissioner may notify the carrier that submitted the request
under paragraph (1) of this subsection before granting access to information that was the
subject of the request.

(4) A carrier shall disclose to a member on request any plan information
contained in a report that is required to be disclosed to that member under federal or State
law.

(i) (1) The Commissioner shall:

– 10 –
END OF PAGE 10

START OF PAGE 11
WES MOORE, Governor Ch. 234

[(1)] (I) review each report submitted in accordance with subsections (c),
(D), and (f) of this section to assess each carrier’s compliance with the Parity Act FOR EACH
PARITY ACT CLASSIFICATION;

[(2)] (II) notify a carrier in writing of any noncompliance with the Parity
Act before issuing an administrative order; and

[(3)] (III) within 90 days after the notice of noncompliance is issued, allow
the carrier to:

[(i)] 1. submit a compliance plan to the Administration to comply
with the Parity Act; and

[(ii)] 2. reprocess any claims that were improperly denied, in
whole or in part, because of the noncompliance.

(2) THE COMMISSIONER MAY EXERCISE DISCRETION TO REVIEW A
~~SUBSET~~ ~~OF~~ ~~NONQUANTITATIVE~~ ~~TREATMENT~~ ~~LIMITATIONS~~ ~~FOR~~ ~~THE~~ ~~PURPOSES~~ ~~OF~~
THIS SECTION IF THE COMMISSIONER:

(I) AFTER THE REPORTING DEADLINES ESTABLISHED UNDER
SUBSECTIONS (C) AND (F) OF THIS SECTION, IDENTIFIES THE NONQUANTITATIVE
TREATMENT LIMITATIONS THAT WILL BE REVIEWED BY THE COMMISSIONER;

(II) DESCRIBES AND POSTS ON THE ADMINISTRATION’S
~~WEBSITE~~ ~~THE~~ ~~CRITERIA~~ ~~USED~~ ~~TO~~ ~~IDENTIFY~~ ~~THE~~ ~~NONQUANTITATIVE~~ ~~TREATMENT~~
LIMITATIONS THAT WILL BE REVIEWED EACH YEAR;

(III) REVIEWS NONQUANTITATIVE TREATMENT LIMITATIONS
~~THAT~~ ~~HAVE~~ ~~THE~~ ~~GREATEST~~ ~~EFFECT~~ ~~ON~~ ~~ACCESS~~ ~~TO~~ ~~MENTAL~~ ~~HEALTH~~ ~~AND~~
SUBSTANCE USE DISORDER CARE;

(IV) REVIEWS THE SAME SUBSET OF NONQUANTITATIVE
TREATMENT LIMITATIONS FOR EACH CARRIER REPORT;

(V) REVIEWS NOT LESS THAN 10 NONQUANTITATIVE
TREATMENT LIMITATIONS FOR EACH CARRIER REPORT; AND

(VI) ISSUES A DETERMINATION IN ANY MATTER THAT
IMPLICATES PARITY ACT COMPLIANCE REGARDLESS OF WHETHER A
~~NONQUANTITATIVE~~ ~~TREATMENT~~ ~~LIMITATION~~ ~~AT~~ ~~ISSUE~~ ~~IN~~ ~~THE~~ ~~MATTER~~ ~~HAS~~ ~~BEEN~~
REVIEWED UNDER THIS SECTION.

– 11 –
END OF PAGE 11

START OF PAGE 12
Ch. 234 2024 LAWS OF MARYLAND

(2) THE COMMISSIONER MAY REQUIRE CARRIERS TO COMPLETE
DATA TEMPLATES FOR A NONQUANTITATIVE TREATMENT LIMITATION MORE
FREQUENTLY THAN EVERY 2 YEARS.

(j) (1) If the Commissioner finds that the carrier failed to submit a complete
report required under subsection (c) or (f) of this section, the Commissioner may:

(I) TAKE ACTION AUTHORIZED UNDER PARAGRAPH (2) OF THIS
SUBSECTION;

(II) IN ACCORDANCE WITH § 2–208 OF THIS ARTICLE, CHARGE
THE CARRIER FOR ANY ADDITIONAL EXPENSES INCURRED BY THE COMMISSIONER
TO REVIEW ADDITIONAL REPORTS;

(III) IMPOSE A PENALTY FOR EACH DAY THAT THE CARRIER
FAILS TO SUBMIT INFORMATION REQUIRED BY THE COMMISSIONER TO EVALUATE
COMPLIANCE; OR

(IV) impose any penalty or take any action as authorized:

(1) 1. for an insurer, nonprofit health service plan, or any other
person subject to this section, under this article; or

(2) 2. for a health maintenance organization, under this article
or the Health – General Article.

(2) IF THE COMMISSIONER CANNOT MAKE A DETERMINATION THAT A
SPECIFIC CONDUCT OR PRACTICE IS COMPLIANT WITH THE PARITY ACT BECAUSE
THE CARRIER FAILED TO PROVIDE A SUFFICIENT COMPARATIVE ANALYSIS FOR A
NONQUANTITATIVE TREATMENT LIMITATION, THE COMMISSIONER MAY:

(I) ISSUE AN ADMINISTRATIVE ORDER REQUIRING THE
CARRIER OR AN ENTITY DELEGATED BY THE CARRIER TO TAKE THE FOLLOWING
ACTION UNTIL THE COMMISSIONER CAN MAKE A DETERMINATION OF COMPLIANCE
WITH THE PARITY ACT:

1. MODIFY THE CONDUCT OR PRACTICE AS SPECIFIED
BY THE COMMISSIONER;

2. CEASE THE CONDUCT OR PRACTICE; OR

3. SUBMIT PERIODIC DATA RELATED TO THE CONDUCT
OR PRACTICE; OR

– 12 –
END OF PAGE 12

START OF PAGE 13
WES MOORE, Governor Ch. 234

(II) SUBJECT TO PARAGRAPH (3) OF THIS SUBSECTION,
REQUIRE THE CARRIER TO PERFORM A NEW COMPARATIVE ANALYSIS.

(3) THE COMMISSIONER MAY REQUIRE THE CARRIER TO ESTABLISH
SPECIFIC QUANTITATIVE THRESHOLDS FOR EVIDENTIARY STANDARDS AND
CONDUCT A NEW COMPARATIVE ANALYSIS FOR A NONQUANTITATIVE TREATMENT
LIMITATION IF THE COMMISSIONER DETERMINES A CARRIER FAILED TO PROVIDE A
SUFFICIENT COMPARATIVE ANALYSIS BECAUSE THE CARRIER DID NOT:

(I) USE APPLICABLE QUANTITATIVE THRESHOLDS FOR THE
EVIDENTIARY STANDARD; OR

(II) PROVIDE A SPECIFIC, DETAILED, AND REASONED
EXPLANATION OF HOW THE CARRIER ENSURES THAT THE FACTORS FOR THE
NONQUANTITATIVE TREATMENT LIMITATION ARE BEING APPLIED COMPARABLY
AND NO MORE STRINGENTLY TO MENTAL HEALTH AND SUBSTANCE USE DISORDER
SERVICES.

(4) SUBSECTION (I)(1)(III) OF THIS SECTION DOES NOT APPLY TO THE
FAILURE OF A CARRIER TO SUBMIT A COMPLETE REPORT.

(k) If, as a result of the review required under subsection [(i)(1)] (I)(1)(I) of this
section, the Commissioner finds that the carrier failed to comply with [the provisions of]
the Parity Act, [and] did not submit a compliance plan to adequately correct the
noncompliance, OR FAILED TO SUBMIT INFORMATION THAT IS REQUIRED TO
EVALUATE COMPLIANCE WITH THE PARITY ACT, the Commissioner may:

(1) issue an administrative order that requires:

(i) the carrier or an entity delegated by the carrier to cease the
noncompliant conduct or practice; [or]

(II) THE CARRIER OR AN ENTITY DELEGATED BY THE CARRIER
~~TO~~ ~~CEASE~~ ~~THE~~ ~~IMPLEMENTATION~~ ~~OF~~ ~~THE~~ ~~NONQUANTITATIVE~~ ~~TREATMENT~~
LIMITATION; OR

[(ii)] (III) the carrier to provide a payment that has been denied
improperly because of the noncompliance, INCLUDING A FAILURE TO PROVIDE
INFORMATION THAT DEMONSTRATES COMPLIANCE; [or]

(2) IMPOSE A PENALTY OF NOT LESS THAN $1,000 FOR EACH DAY IN
~~WHICH~~ ~~THE~~ ~~CARRIER~~ ~~FAILS~~ ~~TO~~ ~~SUBMIT~~ ~~INFORMATION~~ ~~REQUIRED~~ ~~BY~~ ~~THE~~
COMMISSIONER TO EVALUATE COMPLIANCE; OR

– 13 –
END OF PAGE 13

START OF PAGE 14
Ch. 234 2024 LAWS OF MARYLAND

[(2)] (3) impose any OTHER penalty or take any action as authorized:

(i) for an insurer, nonprofit health service plan, or any other person
subject to this section, under this article; or

(ii) for a health maintenance organization, under this article or the
Health – General Article.

(L) (1) A CARRIER SHALL HAVE THE BURDEN OF PERSUASION IN
DEMONSTRATING THAT ITS ~~HEALTH~~ ~~PLAN~~ DESIGN AND APPLICATION OF A
NONQUANTITATIVE TREATMENT LIMITATION COMPLIES WITH THE PARITY ACT:

(I) IN ANY REVIEW CONDUCTED BY THE COMMISSIONER
UNDER THIS SECTION; OR

(II) IN ANY MATTER FILED WITH COMPLAINT INVESTIGATION OR
MARKET CONDUCT ACTION UNDERTAKEN BY THE COMMISSIONER THAT INVOLVES
THE APPLICATION OF THE PARITY ACT.

(2) (I) A FAILURE OF A CARRIER TO SUBMIT COMPLETE PARITY
ACT COMPLIANCE INFORMATION REQUIRED UNDER THIS SECTION OR IN
CONNECTION WITH ~~A~~ ~~MATTER~~ ~~FILED~~ ~~WITH~~ AN INVESTIGATION OR EXAMINATION BY
THE COMMISSIONER SHALL CONSTITUTE NONCOMPLIANCE WITH THE PARITY ACT.

(II) SUBSECTION (I)(1)(III) OF THIS SECTION DOES NOT APPLY
TO A CARRIER THAT FAILS TO SUBMIT COMPLETE PARITY ACT COMPLIANCE
INFORMATION.

[(l)] (M) In determining an appropriate penalty under subsection (j) or (k) of this
section, the Commissioner shall consider the late filing of a report required under
subsection (c) or (f) of this section and any parity violation to be a serious violation with a
significantly deleterious effect on the public.

[(m)] (N) On or before December 31, 2021, the THE Commissioner shall create:

(1) a standard form for entities to submit the reports in accordance with
subsection (g)(1) of this section; and

(2) a summary form for entities to post to their websites in accordance with
subsection (g)(5) of this section.

[(n)] (O) On or before December 31, [2021] 2024, the THE Commissioner shall,
in consultation with interested stakeholders, adopt regulations to implement this section,

– 14 –
END OF PAGE 14

START OF PAGE 15
WES MOORE, Governor Ch. 234

including to ensure uniform definitions and methodology for the reporting requirements
established under this section.

15–1309.

(a) (1) In this section the following words have the meanings indicated.

(3) (i) “Product” means a discrete package of health benefits that are
offered using a particular product network type within a geographic service area.

(ii) “Product” comprises all plans offered within the product.

Chapter 211 of the Acts of 2020

[SECTION 2. AND BE IT FURTHER ENACTED, That the standard form the
Maryland Insurance Commissioner is required to develop under § 15–144(m)(1) of the
Insurance Article, as enacted by Section 1 of this Act, for the report required under §
15–144(c) of the Insurance Article, as enacted by Section 1 of this Act, shall be the National
Association of Insurance Commissioners’ Data Collection Tool for Mental Health Parity
Analysis, Nonquantitative Treatment Limitations and any amendments by the
Commissioner to the tool necessary to incorporate the requirements of § 15–144(c), (d), and
(e) of the Insurance Article, as enacted by Section 1 of this Act.]

SECTION 4. AND BE IT FURTHER ENACTED, That this Act shall take effect
October 1, 2020. [It shall remain in effect for a period of 6 years and, at the end of
September 30, 2026, this Act, with no further action required by the General Assembly,
shall be abrogated and of no further force and effect.]

Chapter 212 of the Acts of 2020

[SECTION 2. AND BE IT FURTHER ENACTED, That the standard form the
Maryland Insurance Commissioner is required to develop under § 15–144(m)(1) of the
Insurance Article, as enacted by Section 1 of this Act, for the report required under §
15–144(c) of the Insurance Article, as enacted by Section 1 of this Act, shall be the National
Association of Insurance Commissioners’ Data Collection Tool for Mental Health Parity
Analysis, Nonquantitative Treatment Limitations and any amendments by the
Commissioner to the tool necessary to incorporate the requirements of § 15–144(c), (d), and
(e) of the Insurance Article, as enacted by Section 1 of this Act.]

SECTION 4. AND BE IT FURTHER ENACTED, That this Act shall take effect
October 1, 2020. [It shall remain in effect for a period of 6 years and, at the end of
September 30, 2026, this Act, with no further action required by the General Assembly,
shall be abrogated and of no further force and effect.]

SECTION 2. AND BE IT FURTHER ENACTED, That this Act ~~shall~~ ~~take~~ ~~effect~~ ~~July~~
~~1,~~ ~~2024~~ is an emergency measure, is necessary for the immediate preservation of the public
– 15 –
END OF PAGE 15

START OF PAGE 16
Ch. 234 2024 LAWS OF MARYLAND

health or safety, has been passed by a yea and nay vote supported by three–fifths of all the
members elected to each of the two Houses of the General Assembly, and shall take effect
from the date it is enacted.

Approved by the Governor, April 25, 2024.

– 16 –
END OF PAGE 16